ZyVersa Therapeutics Statistics
Total Valuation
ZVSA has a market cap or net worth of $1.83 million. The enterprise value is $305,589.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 2.57 million shares outstanding. The number of shares has increased by 1,038.50% in one year.
Current Share Class | 2.57M |
Shares Outstanding | 2.57M |
Shares Change (YoY) | +1,038.50% |
Shares Change (QoQ) | +101.47% |
Owned by Insiders (%) | 0.06% |
Owned by Institutions (%) | 4.03% |
Float | 2.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.21 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.14 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.86 |
Financial Efficiency
Return on equity (ROE) is -96.10% and return on invested capital (ROIC) is -58.27%.
Return on Equity (ROE) | -96.10% |
Return on Assets (ROA) | -26.74% |
Return on Invested Capital (ROIC) | -58.27% |
Return on Capital Employed (ROCE) | -97.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.34M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVSA has paid $6,745 in taxes.
Income Tax | 6,745 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.36% in the last 52 weeks. The beta is 0.68, so ZVSA's price volatility has been lower than the market average.
Beta (5Y) | 0.68 |
52-Week Price Change | -87.36% |
50-Day Moving Average | 0.88 |
200-Day Moving Average | 1.84 |
Relative Strength Index (RSI) | 46.55 |
Average Volume (20 Days) | 6,509,133 |
Short Selling Information
The latest short interest is 109,699, so 4.27% of the outstanding shares have been sold short.
Short Interest | 109,699 |
Short Previous Month | 187,928 |
Short % of Shares Out | 4.27% |
Short % of Float | 4.28% |
Short Ratio (days to cover) | 0.28 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -9.14M |
Pretax Income | -22.42M |
Net Income | -9.41M |
EBITDA | -9.13M |
EBIT | -9.14M |
Earnings Per Share (EPS) | -$8.48 |
Full Income Statement Balance Sheet
The company has $1.53 million in cash and n/a in debt, giving a net cash position of $1.53 million or $0.60 per share.
Cash & Cash Equivalents | 1.53M |
Total Debt | n/a |
Net Cash | 1.53M |
Net Cash Per Share | $0.60 |
Equity (Book Value) | 8.52M |
Book Value Per Share | 3.40 |
Working Capital | -9.52M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -7.56M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |